Savara
SVRA
#5984
Rank
A$1.65 B
Marketcap
A$8.05
Share price
-3.25%
Change (1 day)
120.69%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -A$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.17 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.2 Billion13.9%
2025 -A$0.17 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$77.97 Million43.38%
2022 -A$54.38 Million-11.31%
2021 -A$61.32 Million-13.3%
2020 -A$70.72 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$97.95 Million105.54%
2017 -A$47.66 Million34.11%
2016 -A$35.54 Million-37.43%
2015 -A$56.8 Million38.81%
2014 -A$40.92 Million33.62%
2013 -A$30.62 Million38.49%
2012 -A$22.11 Million24.59%
2011 -A$17.75 Million-36.5%
2010 -A$27.95 Million-3.14%
2009 -A$28.86 Million-23.28%
2008 -A$37.61 Million8.52%
2007 -A$34.66 Million-34.14%
2006 -A$52.62 Million184.43%
2005 -A$18.5 Million90.75%
2004 -A$9.7 Million190.35%
2003 -A$3.35 Million11.64%
2002 -A$3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.33 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.88 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA